The Taiwan Food and Drug Administration (TFDA) announced Wednesday that two measures have been implemented to increase intravenous (IV) fluid supplies after a halt in production by Taiwan's major saline supplier sparked concerns about a shortage of the medical resource crucial for surgery.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares close up 0.03%
03/14/2025 01:45 PM - Sports
Hsieh, Zhang ousted from BNP Paribas Open women's doubles
03/14/2025 12:44 PM - Business
Pegatron plans production in U.S. amid Trump tariff threats
03/14/2025 12:15 PM - Business
U.S. dollar up in Taipei trading
03/14/2025 10:15 AM - Culture
Taiwanese manga artist fulfills dream with award-winning work
03/14/2025 10:13 AM